Protagonist Therapeutics EPS Basic from Extraordinaries (Quarterly) Analysis

Protagonist Therapeutics, Inc. (PTGX)

80.22 +0.02 (+0.02%) USD | NASDAQ | Jan 09, 16:00

80.34 +0.12 (+0.15%) After-Hours: 20:00

View EPS Basic from Extraordinaries (Quarterly) for PTGX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Basic from Extraordinaries (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EPS Basic from Extraordinaries (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Basic from Extraordinaries (Quarterly) Benchmarks

Start Trial

Johnson & Johnson	--
ADMA Biologics, Inc.	--
Bristol Myers Squibb Co.	--
MannKind Corp.	--
Regeneron Pharmaceuticals, Inc.	--